Definitive Contract HHSD200201141913C

This is a $4,410,023.00 firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Nova Southeastern University, Inc., a private, non-profit research university, to conduct research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The contract does not have a set-aside designation. Under this contract, Nova Southeastern University will serve as the prime contractor, with Vanderbilt University Medical Center and the University of Miami acting as...

This contract was awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Synergy America, Inc., an SBA-certified 8(a) and economically disadvantaged woman-owned small business. The contract is for $223,800.00 and is a firm fixed price purchase order with a completion date of September 24, 2021. The contract is for ME/CFS (Myalgic Encephalomyelitis/Chronic Fatigue Syndrome) multi-stakeholder services, which likely includes a range of...

This is a $245,250.00 firm-fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Synergy America, Inc. for an 8(a) sole source contract to conduct a knowledge, attitudes, and practices (KAP) assessment related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Synergy America, Inc. is a certified Economically Disadvantaged Women-Owned Small Business and 8(a) Program Participant providing a range of...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $200,150 firm-fixed-price purchase order to WebMD Health Corp. (doing business as WebMD) to provide a continuing medical education (CME) supplement on Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). This sole-source award was made under the authority of 10 U.S.C. 2304(c)(1) and FAR Subpart 6.302-1, as the CDC determined WebMD was the only responsible source capable of providing...

The Centers for Disease Control and Prevention (CDC) awarded a $45,800 firm fixed price purchase order to Irepertoire Inc., a self-certified small disadvantaged business, to provide immune repertoire sequencing and analysis services. The purpose of the contract is to identify immune repertoire biomarkers for diagnosing and subclassifying Chronic Fatigue Syndrome (CFS) patients. This sole source award was made without a set-aside designation. Irepertoire Inc. specializes in T-cell receptor...

This definitive time and materials contract for $1,380,515.38 was awarded by the Centers for Disease Control and Prevention (CDC) to the National Association of School Nurses, Incorporated (NASN), a non-profit organization. The contract is for services related to school-based surveillance and research initiatives, particularly focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and other chronic conditions in school children. This contract was not set aside for any specific...

Mayo Collaborative Services, Inc. (MCS), doing business as Mayo Clinic Laboratories, has been awarded a firm fixed price purchase order totaling $22,660 by the National Institutes of Health's National Institute of Mental Health. Under this contract, MCS will provide reference laboratory testing services in support of medical research programs at the NIH Clinical Center in Rochester, Minnesota. No set-aside designation was applied to this award. As a prime contractor and subsidiary of Mayo...

Clinical Diagnostic Laboratories, LLC, doing business as Clinical Diagnostic Lab, was awarded a $3.5 million firm-fixed-price definitive contract by the Department of State Bureau of Medical Services to provide on-site biological specimen collection and reverse transcriptase polymerase chain reaction testing for SARS-CoV-2. The one-year base period contract, with four one-year options, will support testing of approximately 180 personnel annually in the Washington, D.C. area through March 2022....

This is a firm fixed-price definitive contract awarded by the Department of Health and Human Services Food and Drug Administration to Duke University on August 26, 2019, with a potential value of $450,000.00 and a completion date of December 1, 2022. The contract is to gather evidence to determine whether modifications are necessary to the Kansas City Cardiomyopathy Questionnaire (KCCQ) to address possible interpretation differences by men and women. As a subcontractor, Mayo Clinic will...

Duke University, as prime contractor, is providing clinical research and immunization safety assessment services under a cost-no-fee delivery order valued at $489,565. This award is issued against the prime IDIQ contract held by Duke University from the Centers for Disease Control and Prevention, entitled "Phase I Clinical Trials for Development of Neurotherapeutics", with a potential value of $86 million through September 2028. No set-aside designation was used for this delivery...